tag:blogger.com,1999:blog-1474751880645498536.post4196622418370579624..comments2023-10-10T10:14:36.340-04:00Comments on Medical Evidence Blog: The EOLIA ECMO Bayesian Reanalysis in JAMAScott K. Aberegg, M.D., M.P.H.http://www.blogger.com/profile/17564774546019869201noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-1474751880645498536.post-80737810634161151462019-04-25T15:19:49.048-04:002019-04-25T15:19:49.048-04:00https://www.nejm.org/doi/full/10.1056/NEJMclde1804...https://www.nejm.org/doi/full/10.1056/NEJMclde1804601<br />Scott K. Aberegg, M.D., M.P.H.https://www.blogger.com/profile/17564774546019869201noreply@blogger.comtag:blogger.com,1999:blog-1474751880645498536.post-29597847873214587292019-04-25T15:19:41.266-04:002019-04-25T15:19:41.266-04:00Here, on the NEJM website is a poll, showing 81% w...Here, on the NEJM website is a poll, showing 81% would initiate ECMO for the patient in the vignette, suggesting much stronger support than I anticipated for ECMO. There were 4000 responses. It is a convenience sample with unknown representativeness, but the effect is strong, so I'm guessing the majority of the community at large does indeed support ECMO, at least for persistent arterial hypoxemia with sats in the 80-82% range, like was presented in the vignette.Scott K. Aberegg, M.D., M.P.H.https://www.blogger.com/profile/17564774546019869201noreply@blogger.com